Zerone Cellvane and Cosmax NBT have signed an MOU for joint research and development of health food products.

Zerone Cellvane and Cosmax NBT have signed an MOU for joint research and development focusing on oral and bone health care products. This collaboration will emphasize studying and researching formulas to create health supplements for good health.

The MOU also includes collaboration in government research and development projects to transform drugs and cosmetics into health supplements. This new development direction focuses on treating inflammation and tissue regeneration. Zerone Cellvane manufactures "Cellvane Injection," which focuses on pain relief, inflammation, and age-related diseases, while Cosmax NBT is a leader in developing ingredients for products that are widely accepted both domestically and internationally.

The management of Zerone Cellvane expressed confidence in the ability to develop together with Cosmax NBT, stating, "We have high hopes for the progress of our development with Cosmax NBT," and believe that Zerone Cellvane's research capabilities will be an opportunity for various developments. This is a new development direction focusing on treating inflammation, tissue regeneration, and repairing damaged cells.